Hospital Care for Heart Attack, Heart Failure Patients Varies Across Nation
Posted on: Thursday, 9 July 2009, 04:00 CDT
Researchers analyzed findings from the 2009 Centers for Medicare and Medicaid Services (CMS) 30-day outcomes report for acute myocardial infarction (heart attack) and heart failure, part of the CMS Hospital Compare quality initiative.
Researchers reviewed three years of experience (
- The average 30-day death rate for heart attack was 16.6 percent and the average rate of heart attack readmission was 19.9 percent.
- The average 30-day death rate for heart failure was 11.1 percent and 24.4 percent for readmission.
The researchers said their findings represent an opportunity for improvement.
"If we just look at readmission, one in four patients who has heart failure and one in five who has a heart attack is back in the hospital within 30 days for readmission," said
Researchers also found:
- Heart failure death rate ranged from 6.6 percent to 19.8 percent.
- Readmission for heart attack ranged from 15.3 percent to 29.4 percent.
- Readmission for heart failure ranged from 15.9 percent to 34.4 percent.
"This suggests that patients' outcomes are dependent, at least in part, on the hospital that provides their care," Krumholz said. "What we seem to have here are differences among hospitals that are based on quality and the systems that they have in place. If we could better understand how the best hospitals achieve their results and help the hospitals that are not doing as well improve, we could save many more lives."
He said the release and analysis of the CMS data may now make that possible.
"Hospitals, consumers and others can see how individual hospitals are performing when it comes to heart attack and heart failure care," he said. "The hope is that this information will stimulate constructive engagement by the healthcare community to find ways to improve performance and patient outcomes."
"These repeat hospitalizations often happen within 30 days of a prior hospitalization for the same illness and cost CMS and other payers billions of dollars on an annual basis," said
Treating patients with evidenced-based medicine known to improve health outcomes is the most effective therapy, he said.
"We currently have a robust amount of information now captured in our clinical practice guidelines that truly inform and can guide practitioners in caring for heart attack and heart failure patients," Yancy said. "Quality improvement initiatives such as the suite of the American Heart Association's Get With The Guidelines programs provide a ready solution to help hospitals and healthcare providers follow these guidelines demonstrated to improve care. We know that best outcomes are realized when the best quality of care is provided."
"Hospitals participating in Get With The Guidelines have shown substantial improvements in the use of evidence-based, guideline-recommended therapies for patients with heart attack and patients with heart failure - including those therapies most closely linked to better 30-day clinical outcomes," said
"However, there are still many hospitals that are not participating in quality improvement programs and, as this new study demonstrates, there remain substantial opportunities to improve care and reduce variation in the clinical outcomes for heart attack and heart failure patients nationwide," Fonarow said.
Co-authors are
The study was funded by the U.S. Centers for Medicare & Medicaid Services.
Statements and conclusions of study authors published in American Heart Association scientific journals are solely those of the study authors and do not necessarily reflect the association's policy or position. The association makes no representation or guarantee as to their accuracy or reliability. The association receives funding primarily from individuals. Foundations and corporations (including pharmaceutical, device manufacturers and other companies) also make donations and fund specific association programs and events. The association has strict policies to prevent these relationships from influencing the science content. Revenues from pharmaceutical and device corporations are available at www.americanheart.org/corporatefunding.
Editor's Note: For more information on the American Heart Association's Get With the Guidelines program, visit www.americanheart.org/getwiththeguidelines.
SOURCE American Heart Association
Source: PR Newswire
Related Articles
- Ticagrelor Reduced Cardiovascular Deaths and Heart Attacks in ACS Patients Undergoing Heart Procedures: New Data from PLATO Trial
- University of Ottawa Heart Institute Trial Finds Popular Blood Clotting Drug Does Not Improve Patient Outcomes and Increases Risk of Bleeding
- Prasugrel Significantly Reduced New or Recurrent Heart Attacks in Both Acute and Longer-Term Settings Following PCI, Compared With Clopidogrel
- Faster Heart-Attack Care Coming to Michigan Hospitals
- Pfizer Says Lipitor Reduces Heart Attacks in Kidney Patients
- Heart attack predictors different in men and women
- Heart Attack Deaths Higher Among Blacks
- Hospitals Improve 'Report Card' Scores ; Graded on Heart Attack, Pneumonia Care
- Delays Raise Risk After Heart Attacks
- Painkiller Linked to 140,000 Heart Attacks in Patients
User Comments (0)

RSS Feeds